Coherent Raman Scattering Microscopy in Oncology Pharmacokinetic Research

Junjie Zeng1, Wenying Zhao1, Shuhua Yue1,2

  • 1Institute of Medical Photonics, Beijing Advanced Innovation Center for Biomedical Engineering, School of Biological Science and Medical Engineering, Beihang University, Beijing, China.

Frontiers in Pharmacology
|February 22, 2021
PubMed

Insights

Coherent Raman scattering microscopy offers a label-free imaging solution to overcome challenges in anti-cancer drug development. This advanced technique provides high-resolution, chemical insights for improved oncology pharmacokinetic studies.

Area of Science:

  • Oncology
  • Pharmacology
  • Microscopy
  • Chemical Imaging

Background:

  • High attrition rates of anti-cancer drugs in clinical development are a significant bottleneck.
  • Current methods lack quantitative, selective, and rapid readouts of drug activity in situ.
  • Fluorescent labels used in microscopy can interfere with drug molecules.

Purpose of the Study:

  • To review the latest applications of coherent Raman scattering (CRS) microscopy in oncology.
  • To highlight CRS microscopy as an emerging platform for facilitating pharmacokinetic research of anti-cancer drugs.

Main Methods:

  • Coherent Raman scattering microscopy enables label-free imaging.
  • This technique offers chemical selectivity, high sensitivity, and high spatial resolution.
  • It allows for high-speed imaging without perturbing drug molecules.

Main Results:

  • CRS microscopy has advanced the understanding of pharmaceutical materials in the solid state.
  • It has improved the study of pharmacokinetics for anti-cancer drugs and nanocarriers in vitro and in vivo.
  • CRS microscopy overcomes limitations associated with fluorescent labeling.

Conclusions:

  • Coherent Raman scattering microscopy is a powerful, emerging tool for oncology research.
  • Its label-free, high-resolution capabilities address critical needs in drug development.
  • CRS microscopy significantly enhances the study of anti-cancer drug pharmacokinetics.

Related Concept Videos

Raman Spectroscopy: Overview01:20

Raman Spectroscopy: Overview

The underlying principle of Raman spectroscopy is based on the interaction between light and matter, specifically molecules' inelastic scattering of photons. When a monochromatic beam of light, typically from a laser source, interacts with a sample, most scattered light has the same frequency as the incident light. This is known as Rayleigh scattering.
However, a small fraction of the scattered light exhibits a frequency shift due to the exchange of energy between the incident photons and...
944
Raman Spectroscopy Instrumentation: Overview01:26

Raman Spectroscopy Instrumentation: Overview

A conventional Raman spectrophotometer includes a laser source, a sample holding system, a wavelength selector, and a detector.
The monochromatic laser source, typically using visible or near-infrared radiation, generates a highly focused beam of light. This light interacts with the molecules of the sample, scattering some of the light. Liquid and gaseous samples are usually tested in ordinary glass capillaries, while solids can be analyzed as powders packed in capillaries or as potassium...
658
Measurement of Bioavailability: Pharmacodynamic Methods01:20

Measurement of Bioavailability: Pharmacodynamic Methods

Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
82